1 |
The efficacy and safety of Dipeptyl Peptidase-4 inhibitors compared to other Oral glucose-lowering medications in the treatment of type 2 diabetes |
|
| | Anca Pantea Stoian,Alexandros Sachinidis,Roxana Adriana Stoica,Dragana Nikolic,Angelo Maria Patti,Ali A. Rizvi | | | Metabolism. 2020; : 154295 | | | [Pubmed] [Google Scholar] [DOI] | |
|